Credit Suisse’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $840K | Hold |
125,310
| – | – | ﹤0.01% | 2371 |
|
|
2023
Q4 | $815K | Buy |
125,310
+45,643
| +57% | +$294K | ﹤0.01% | 2467 |
|
|
2023
Q3 | $752K | Sell |
79,667
-18,720
| -19% | -$225K | ﹤0.01% | 2464 |
|
|
2023
Q2 | $1.37M | Buy |
98,387
+23,773
| +32% | +$405K | ﹤0.01% | 2171 |
|
|
2023
Q1 | $1.4M | Buy |
74,614
+1,583
| +2% | +$26K | ﹤0.01% | 2095 |
|
|
2022
Q4 | $1.01M | Buy |
73,031
+2,605
| +4% | +$39.9K | ﹤0.01% | 2344 |
|
|
2022
Q3 | $1.35M | Buy |
70,426
+5,204
| +8% | +$94.8K | ﹤0.01% | 2111 |
|
|
2022
Q2 | $995K | Sell |
65,222
-23,707
| -27% | -$351K | ﹤0.01% | 2389 |
|
|
2022
Q1 | $1.81M | Buy |
88,929
+19,331
| +28% | +$394K | ﹤0.01% | 2154 |
|
|
2021
Q4 | $2.03M | Buy |
69,598
+693
| +1% | +$19.8K | ﹤0.01% | 2777 |
|
|
2021
Q3 | $1.49M | Buy |
68,905
+30,326
| +79% | +$732K | ﹤0.01% | 3043 |
|
|
2021
Q2 | $990K | Buy |
+38,579
| New | +$824K | ﹤0.01% | 3390 |
|
|
2021
Q1 | – | Sell |
-18,024
| Closed | -$208K | – | 4619 |
|
|
2020
Q4 | $208K | Buy |
+18,024
| New | +$165K | ﹤0.01% | 4085 |
|
|
2019
Q4 | – | Sell |
-12,444
| Closed | -$65K | – | 4369 |
|
|
2019
Q3 | $65K | Buy |
12,444
+419
| +3% | +$2.6K | ﹤0.01% | 4012 |
|
|
2019
Q2 | $67K | Buy |
12,025
+203
| +2% | +$837 | ﹤0.01% | 3978 |
|
|
2019
Q1 | $50K | Buy |
+11,822
| New | +$48.2K | ﹤0.01% | 3901 |
|
|
2018
Q3 | – | Sell |
-13,710
| Closed | -$54K | – | 4038 |
|
|
2018
Q2 | $54K | Buy |
+13,710
| New | +$47.6K | ﹤0.01% | 3896 |
|
|
2016
Q3 | – | Sell |
-62,502
| Closed | -$159K | – | 4289 |
|
|
2016
Q2 | $159K | Buy |
62,502
+59,559
| +2,024% | +$166K | ﹤0.01% | 3947 |
|
|
2016
Q1 | $9K | Sell |
2,943
-3,335
| -53% | -$17.8K | ﹤0.01% | 3942 |
|
|
2015
Q4 | $51K | Sell |
6,278
-3,384
| -35% | -$27.3K | ﹤0.01% | 4134 |
|
|
2015
Q3 | $69K | Buy |
9,662
+693
| +8% | +$5.78K | ﹤0.01% | 4150 |
|
|
2015
Q2 | $83K | Buy |
8,969
+4,438
| +98% | +$42.7K | ﹤0.01% | 4411 |
|
|
2015
Q1 | $43K | Sell |
4,531
-1,775
| -28% | -$17.1K | ﹤0.01% | 4289 |
|
|
2014
Q4 | $61K | Buy |
6,306
+697
| +12% | +$7.02K | ﹤0.01% | 4506 |
|
|
2014
Q3 | $54K | Sell |
5,609
-6,138
| -52% | -$68.7K | ﹤0.01% | 4354 |
|
|
2014
Q2 | $154K | Sell |
11,747
-6,880
| -37% | -$86.7K | ﹤0.01% | 4449 |
|
|
2014
Q1 | $248K | Sell |
18,627
-1,304
| -7% | -$17.2K | ﹤0.01% | 4218 |
|
|
2013
Q4 | $193K | Buy |
19,931
+2,531
| +15% | +$23.8K | ﹤0.01% | 4343 |
|
|
2013
Q3 | $170K | Buy |
17,400
+6,625
| +61% | +$65.8K | ﹤0.01% | 4011 |
|
|
2013
Q2 | $97K | Buy |
+10,775
| New | +$113K | ﹤0.01% | 4023 |
|
Other funds holding CDMO
AC
1WCM
SCM
PCM
PAIM
Credit Suisse's CDMO Position: Q1 2024 in Review
Credit Suisse held its Avid Bioservices, Inc. Common Stock (CDMO) position steady in Q1 2024 at 125,310 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.
Credit Suisse first reported a position in CDMO in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.03M in Q4 2021. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.
- Credit Suisse held 125,310 shares of Avid Bioservices, Inc. Common Stock worth $840K as of Q1 2024.
- Credit Suisse left its Avid Bioservices, Inc. Common Stock share count unchanged in Q1 2024.
- Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2371 holding.
- Credit Suisse first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and has held it in 30 quarters since.
- Credit Suisse's Avid Bioservices, Inc. Common Stock position peaked at $2.03M in Q4 2021.
- 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.